ClinicalTrials.gg
RecruitingNCT05954533Updated Mar 8, 2024

HEAVEN CRITERIA vs Modified LEMON Score for Predicting Difficult Intubation

An observational study in Intubation; Difficult or Failed and Intubation Complication, sponsored by Jubilee Mission Medical College and Research Institute. Recruiting at 1 site in India. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by Jubilee Mission Medical College and Research Institute · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Jul 2022; still recruiting 4 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
192
Sex
All
01

Study summary

Emergency tracheal intubation is a lifesaving procedure frequently performed on critically ill and injured patients in the emergency department (ED). Emergency intubations are more difficult than elective intubations in the operating room setting because of the sicker patient population with a limited physiologic reserve and less controlled setting in the ED. Indeed, the proportion of difficult intubation ranges from 10% to 27% in the ED setting , whereas the rate ranges from 1% to 9% of elective intubation in the anaesthesia setting. Because emerging evidence demonstrates that repeated intubation attempts are associated with an increased risk of adverse events, early recognition of difficulty intubation with a systematic use of rescue methods in ED patients is critical. The commonest airway prediction tool is the LEMON score. In the modified LEMON score "Mallampati" was excluded as it was not a pragmatic assessment in the ED.

Existing difficult airway prediction tools were derived in the elective surgery environment and may not be applicable to emergency airway management. LEMON criteria was designed for preoperative clinical setting.

Hence in this study we are observing if HEAVEN (H- Hypoxemia E - extremes of age A - anatomical abnormalities V - vomit/ blood / fluid E - Exsanguination/anaemia N - neck mobility issues) is a better tool for predicting difficult intubatio.

02

Conditions studied

  • Intubation; Difficult or Failed
  • Intubation Complication

Keywords

  • HEAVEN criteria
  • Modified LEMON
  • Difficult airway
  • Prediction tool
03

In context

Lead sponsor

Jubilee Mission Medical College and Research Institute is the lead sponsor of 25 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients from all age groups requiring endotracheal intubation and who gives consent for the study would be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. All patients who undergo an endotracheal intubation in the emergency medicine department and 2. who legally give consent for the study or relatives give consent

Exclusion criteria

Exclusion Criteria:

  • Patients not consenting for the study or · Patients in cardio respiratory arrest
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
192 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. First attempt intubation success rate

    First attempt success would be defined as the placement of an endotracheal tube in the trachea with a single insertion of a laryngoscope blade into the mouth and either a single insertion of an endotracheal tube into the mouth or a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube into the mouth

    Time frame: Two hours

  2. Physicians assessment of intubation as easy or difficult

    Physicians subjective assessment of airway as easy or difficult

    Time frame: Two hours

Secondary outcomes

  1. Total attempts of intubation.

    Total number of attempts is divided into less than 10 number of attempts, 10 to 100 and \>100attempts

    Time frame: Two hours

  2. Which criteria was the most frequent in causing difficult airway among HEAVEN

    Time frame: Two hours

  3. Measuring if patient had hypotension

    SBP 100 and 20% decrease from baseline

    Time frame: 2 hours

  4. Measuring if patient had hypertension

    SBP \>160 and 20% increase from baseline

    Time frame: 2 hours

  5. Measurement of bradycardia

    Adults: HR \< 40bpm and 20% decrease from baseline Paeds \<12yrs: \<60beats/min requiring atropine

    Time frame: Two hours

07

Study locations

1 of 1 sites recruiting
  • JMMCRI
    Thrissur, Kerala 680005, India
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2022 (actual). Primary completion is estimated for Jun 2024, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2023
First posted
Jul 20, 2023
StartActual
Jul 1, 2022
Primary completionEst.
Jun 1, 2024
CompletionEst.
Jul 1, 2024
Last update
Mar 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05954533
Lead sponsor
Jubilee Mission Medical College and Research Institute
Responsible party
Dr Jaismol James (Junior Resident, Jubilee Mission Medical College and Research Institute) — Principal investigator
First posted
Jul 20, 2023
Start date
Jul 1, 2022
Primary completion
Jun 1, 2024 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Mar 8, 2024

Study contacts

JAISMOL JAMES, MBBS
Contact
jaismoljames.16@gmail.com
91 9496660433
Dr. APPU SUSEEL, MBBS, MD
Contact
appuariyedath@gmail.com
91 9847749706
DR APPU SUSEEL, MBBS,MD
study director · JMMCRI
DR SIJU V ABRAHAM, MBBS,MD
study director · JMMCRI

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion